Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Chiara, M. Bruzzone, L. Merlini (1994)
Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)Am J Clin Oncol, 17
W. Peters, P. Liu, R. Barrett, R. Stock, B. Monk, J. Berek, L. Souhami, P. Grigsby, W. Gordon, D. Alberts (2000)
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 8
S. Chiara, M. Bruzzone, L. Merlini, P. Bruzzi, R. Rosso, P. Franzone, M. Orsatti, V. Vitale, G. Foglia, F. Odicino, N. Ragni, S. Rugiati, P. Conte (1994)
Randomized Study Comparing Chemotherapy Plus Radiotherapy Versus Radiotherapy Alone in FIGO Stage IIB‐III Cervical CarcinomaAmerican Journal of Clinical Oncology, 17
A. Jemal, Taylor Murray, A. Samuels, Asma Ghafoor, Elizabeth Ward, M. Thun (2003)
Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 53
Toru Sugiyama, Takashi Nishida, Y. Hasuo, K. Fujiyoshi, Michiaki Yakushiji (1998)
Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.Gynecologic oncology, 69 2
G. Thomas (1999)
Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy.The New England journal of medicine, 340 15
David Alberts, Richard Kronmal, Laurence Baker, Donna Stock-Novack, E. Surwit, J. Boutselis, E. Hannigan (1987)
Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 5 11
F. Leborgne, J.H. Leborgne, R. Doldan (1997)
Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a randomized phase III randomized trialInt J Radiat Oncol Biol Phys, 37
R. Wit, J. Zee, M. Burg, W Kruit, A. Logmans, G. Rhoon, J. Verweij (1999)
A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervixBritish Journal of Cancer, 80
J. Wheelock, H. Krebs, D. Goplerud, M. Myers (1985)
Cis-Platinum, Doxorubicin, and Methotrexate Treatment for Recurrent Cervical CancerObstetrics & Gynecology, 66
C. Stanhope, R. Symmonds (1985)
Palliative exenteration--what, when, and why?American journal of obstetrics and gynecology, 152 1
M. Grogan, G. Thomas, I. Melamed, F. Wong, R. Pearcey, Paul Joseph, L. Portelance, J. Crook, Keith Jones (1999)
The importance of hemoglobin levels during radiotherapy for carcinoma of the cervixCancer, 86
A. Schneider, M. Possover, S. Kamprath, U. Endisch, N. Krause, H. Nöschel (1996)
Laparoscopy-assisted radical vaginal hysterectomy modified according to Schauta-Stoeckel.Obstetrics and gynecology, 88 6
R. Boronow (2000)
The bulky 6-cm barrel-shaped lesion of the cervix: primary surgery and postoperative chemoradiation.Gynecologic oncology, 78 3 Pt 1
M. Tattersall, V. Lorvidhaya, V. Vootiprux, A. Cheirsilpa, F. Wong, T. Azhar, H. Lee, S. Kang, A. Manalo, M. Yen (1995)
Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 13 2
J. Edmonson, P. Johnson, H. Wieand, G. Malkasian, S. Cullinan, L. Brown, J. Mailliard, J. Jefferies (1988)
Phase II Studies of Bleomycin, Cyclophosphamide, Doxorubicin and Cisplatin, and Bleomycin and Cisplatin in Advanced Cervical CarcinomaAmerican Journal of Clinical Oncology, 11
H. Smith, Michael Tiffany, C. Qualls, C. Key (2000)
The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.Gynecologic oncology, 78 2
L. Kumar, R. Kaushal, M. Nandy, B. Biswal, S. Kumar, A. Kriplani, Rajveer Singh, G. Rath, V. Kochupillai (1994)
Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study.Gynecologic oncology, 54 3
G. Omura (1996)
Chemotherapy for stage IVB or recurrent cancer of the uterine cervix.Journal of the National Cancer Institute. Monographs, 21
H. Keys, Brian Bundy, F. Stehman, L. Muderspach, W. Chafe, C. Suggs, J. Walker, D. Gersell (1999)
Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.The New England journal of medicine, 340 15
Peter Rose, Brian Bundy, Edwin Watkins, J. Thigpen, Gunther Deppe, Mitchell Maiman, D. Clarke‐Pearson, Sam Insalaco (1999)
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.The New England journal of medicine, 340 15
P. Bonomi, J.A. Blessing, F.B. Stehman (1989)
Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyGynecol Oncol, 32
J. Bloss, J. Blessing, B. Behrens, R. Mannel, J. Rader, A. Sood, M. Markman, J. Benda (2002)
Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 7
D. Rein, C. Kurbacher, M. Breidenbach, T. Schöndorf, T. Schmidt, E. König, U. Göhring, J. Blohmer, P. Mallmann (2002)
Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer: a phase I study.Gynecologic oncology, 87 1
J. Edmondson, P. Johnson, H.S. Wieand (1988)
Phase II studies of bleomycin and cisplatin in advanced cervical carcinomaAm J Clin Oncol, 11
A. Fyles, A. Fyles, M. Milosevic, M. Milosevic, M. Pintilie, A. Syed, R. Hill, R. Hill (2000)
Anemia, hypoxia and transfusion in patients with cervix cancer: a review.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 57 1
F. Fossella, Jangsoon Lee, D. Shin, Maria Calayag, M. Huber, R. Perez-soler, W. Murphy, S. Lippman, Benner Se, B. Glisson (1995)
Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 13 3
D.M. Parkin, P. Pisani, J. Ferlay (1999)
Global cancer statisticsCancer J Clin, 49
L. Souhami, R. Gil, S. Allan, P. Canary, C. Araújo, L. Pinto, T. Silveira (1991)
A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 9 6
Gillian Thomas, A. Dembo, Ida Ackerman, E. Franssen, Judith Balogh, A. Fyles, W. Levin (1998)
A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer.Gynecologic oncology, 69 2
M. Friedlander, S. Kaye, A. Sullivan, K. Atkinson, P. Elliott, Malcolm Coppleson, R. Houghton, J. Solomon, D. Green, Pamela Russell, C. Hudson, A. Langlands, M. Tattersall (1983)
Cervical carcinoma: a drug-responsive tumor--experience with combined cisplatin, vinblastine, and bleomycin therapy.Gynecologic oncology, 16 2
D. Moore, J. Blessing, R. McQuellon, H. Thaler, D. Cella, J. Benda, D. Miller, G. Olt, S. King, J. Boggess, T. Rocereto (2004)
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 15
W. Hoskins, C. Perez, R. Young (1992)
Principles and Practice of Gynecologic Oncology
C. Perez, R. Kurman, F. Stehman (1992)
Principles and practice of gynecologic oncology group
E. Eisenhauer, J. Vermorken (1996)
New drugs in gynecologic oncology.Current opinion in oncology, 8 5
C. Matthews, M. Morris, T. Burke, D. Gershenson, J. Wharton, F. Rutledge (1992)
Pelvic Exenteration in the Elderly PatientObstetrics & Gynecology, 79
D. Brenner (1987)
Cervix cancer
V. Devita, S. Hellman, S. Rosenberg (1982)
Cancer : Principles and Practice of Oncology
A. Obermair, R. Cheuk, K. Horwood, M. Janda, B. Bachtiary, Barbara Schwanzelberger, Alexander Stoiber, J. Nicklin, L. Perrin, A. Crandon (2001)
Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinomaCancer, 92
D. Brenner (1987)
Combination chemotherapy of advanced cervix cancer
F. Leborgne, J. Leborgne, Raquel Doldan, E. Zubizarreta, B. Ortega, Juan Maisonneuve, E. Musetti, Luciano Hekimian, J. Mezzera (1997)
Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial.International journal of radiation oncology, biology, physics, 37 2
C. Whitney, W. Sause, B. Bundy, J. Malfetano, E. Hannigan, W. Fowler, D. Clarke‐Pearson, S. Liao (1999)
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 5
M. Morris, P. Eifel, Jiandong Lu, P. Grigsby, C. Levenback, R. Stevens, M. Rotman, D. Gershenson, D. Mutch (1999)
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.The New England journal of medicine, 340 15
R. Estape, R. Angioli (1999)
Surgical management of advanced and recurrent cervical cancer.Seminars in surgical oncology, 16 3
M. Tattersall, C. Ramirez, M. Coppleson (1992)
A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases.Gynecologic oncology, 46 2
D.T. Rein, C.M. Kurbacher, M. Breidenbach (2001)
Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer [abstract]Proc Am Soc Clin Oncol, 20
M. Finan, S. Decesare, J. Fiorica, R. Chambers, M. Hoffman, R. Kline, W. Roberts, D. Cavanagh (1996)
Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?Gynecologic oncology, 62 2
J. Thigpen, J. Blessing, P. Disaia, Wesley Fowler, Kenneth Hatch (1989)
A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study.Gynecologic oncology, 32 2
S. Pecorelli (2002)
The Italian gynecological consensus statement on the use of epoetin alfa in the management of anemia.Seminars in oncology, 29 3 Suppl 8
J. Sardi, G. Paola, A. Cachau, O. Ortiz, C. Sananes, A. Giaroli, D. Martins, M. Peluffo (1986)
A possible new trend in the management of the carcinoma of the cervix uteri.Gynecologic oncology, 25 2
Tattersall Mh (1996)
Concomitant and neoadjuvant chemotherapy in conjunction with radiotherapy in the management of locally advanced cervical cancer.Journal of The National Cancer Institute Monographs
Kolbein Sundf;ZZr, C. Tropé, T. Högberg, M. Onsrud, Janne Kœrn, E. Simonsen, K. Bertelsen, R. Westberg (1996)
Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma: A randomized multicenter study of sequential cisplatin and 5‐fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4ACancer, 77
H. Shingleton, S. Soong, M. Gelder, K. Hatch, V. Baker, M. Austin (1989)
Clinical and Histopathologic Factors Predicting Recurrence and Survival After Pelvic Exenteration for Cancer of the CervixAmerican Journal of Obstetrics and Gynecology, 73
T. Chang, C. Lai, Ji-Hong Hong, S. Hsueh, Kuan-Gen Huang, H. Chou, C. Tseng, C. Tsai, J. Chang, Cheng‐Tao Lin, Huei-Hsin Chang, Pei-Jung Chao, K. Ng, S. Tang, Y. Soong (2000)
Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 8
Prudence Francis, J. Schneider, L. Hann, C. Balmaceda, Richard Barakat, M. Phillips, T. Hakes (1994)
Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 11
P. Bonomi, J. Blessing, F. Stehman, P. Disaia, L. Walton, F. Major (1985)
Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 3 8
J. Arseneau, J. Blessing, F. Stehman, R. McGehee (2004)
A Phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group study)Investigational New Drugs, 4
J. Wheelock, H. Krebs, D. Goplerud (1985)
Cisplatinum, doxorubicin, and methotrexate for recurrent cervical cancerObstet Gynecol, 66
P. Bonomi, J. Blessing, H. Ball, P. Hanjani, P. Disaia (1989)
A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervixGynecologic Oncology, 32
J. Chauvergne, J. Héron, F. Mayer, P. Charrot-Chinet, C. Toulouse (1993)
[Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].Bulletin du cancer, 80 1
The prognosis of patients with cervical cancer has improved dramatically in the last 20 years due to the success of systematic screening programs; however, the disease remains a major health problem worldwide. Patients with advanced, recurrent or metastatic disease still have a poor prognosis. Over the last century, radical surgery and radiotherapy have been used to improve survival rates in patients with primary cervical cancer. Both methods have been extensively modified over the years; however, neither improvements in surgical therapy (e.g. radical lymph node dissection) nor modified radiotherapy methods (e.g. neutron irradiation, hyperthermia, interstitial brachytherapy) have significantly decreased the mortality rates. Recently, cooperative clinical trials have demonstrated the superiority of multimodality strategies for patients with high-risk cervical cancer. In these studies, chemotherapy has been integrated into primary therapy; results have shown the most significant improvement of locally advanced disease in more than three decades. The introduction of modern surgical techniques, such as laparoscopic lymphonodectomy and radical pelvic exenteration, are new developments that will change the treatment of cervical cancer in the near future. This review summarizes different aspects of cervical cancer therapy, with emphasis on invasive disease, and provides a perspective on developments which may improve both local and systemic treatment of the disease.
American Journal of Cancer – Springer Journals
Published: Aug 9, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.